Approvals/TGA/ARNUITY ELLIPTA fluticasone furoate 200 microgram powder for inhalation dry powder inhaler

Approved

STANDARD

ARNUITY ELLIPTA fluticasone furoate 200 microgram powder for inhalation dry powder inhaler

GlaxoSmithKline Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: d8a53cf06661c385
Product Name: ARNUITY ELLIPTA fluticasone furoate 200 microgram powder for inhalation dry powder inhaler
Artg Id: 231103
Artg Name: ARNUITY ELLIPTA fluticasone furoate 200 microgram powder for inhalation dry powder inhaler
Sponsor: GlaxoSmithKline Australia Pty Ltd
Company Detail Path: /organization/glaxosmithkline-australia-pty-ltd
Artg Date: 2015-09-11
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/a26049d2401f13f9a88f7a73b3959d0a.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/ce735cbc6c3df6ce893bd8a9c5aef2d6.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

d8a53cf06661c385

Type

Standard